glp-1 news oct 21 2025 Pipeline Update: August - Prime Therapeutics ISPOR 2025: Exploring reasons for
Description
FDA approves Novo Nordisks first oral GLP-1 pill Wegovy for obesity, offering an injection-free option and improving long-term treatment adherence.
However, the cost can be steep, reaching hundreds of dollars per month
No injections
See flat-rate GLP-1 pricing and learn if Peak avoids the Price-Safety Trap with real medical oversight.
D-Panthenol (Vitamin B5)
